SUPROL
THERAPEUTIC AREA: Oncology
ACTIVE PRINCIPLE: Trifluridine and Tipiracil
PRESENTATION: 15mg/6.14mg and 20mg/8.19mg coated tablets
INDICATION:
- Metastatic Colorectal Cancer
COUNTRIES WHERE IT IS MARKETED:
